Effect of Phosphodiesterase-5 Inhibition With Tadalafil on SystEmic Right VEntricular Size and Function

NCT03049540 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

100

Enrollment

OTHER

Sponsor class

Conditions

Heart Defects, Congenital
Transposition of Great Vessels With Ventricular Inversion

Interventions

DRUG: Tadalafil 20 MG
DRUG: Placebo 20 MG

Sponsor

Insel Gruppe AG, University Hospital Bern

Collaborators

[object Object]